RxDoctor Payments Data

Jane Paino, MD

Family Medicine · North Port, FLNPI 1497837363

Payments from drug & device makers

$9,938in general payments, 2019–2025

Across 385 payments — averaging $25.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • AbbVie$976
  • Novo Nordisk$809
  • Amgen$717
  • Corcept Therapeutics$694
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$9,83899%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,938 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$138,083
Medicare patients
307
Services billed
2,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$122,021
OzempicSemaglutide86$109,069
JardianceEmpagliflozin95$104,518
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$56,109
XareltoRivaroxaban26$42,372
FarxigaDapagliflozin Propanediol25$36,437
JanuviaSitagliptin Phosphate18$25,752
MounjaroTirzepatide16$19,132
Bydureon BciseExenatide Microspheres11$8,953
MovantikNaloxegol Oxalate13$5,401
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,141
Atorvastatin Calcium640$4,748
Solifenacin Succinate28$4,604
Levothyroxine Sodium461$4,481
Fenofibrate23$4,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$674$123,451121 claims
Novo NordiskOzempic$809$109,06986 claims
Boehringer IngelheimJardiance$123$104,51895 claims
GSKTrelegy Ellipta, Anoro Ellipta$626$61,24982 claims
AstraZenecaFarxiga$1,283$36,43725 claims
MerckJanuvia$51$25,75218 claims
Lilly USA, LLCMounjaro$1,185$19,13216 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$4,481461 claims
AbbVieSynthroid$976$2,29631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in North Port

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →